ÖGMBT Working Group Cell Based Assays, Therapies and Products
About
Head of Working Group
Dr. Isita Sagar (CV)
Deputy Head – Head of Institute of Cell and Tissue Culture Technologies,
University of Natural Resources and Life Sciences, Vienna
Vice-Head of Working Group

Univ.Prof. Dipl.-Chem. Dr. Cornelia Kasper
Head of Institute of Cell and Tissue Culture Technologies,
University of Natural Resources and Life Sciences, Vienna
Contact us
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Find out more about the working group and our workshops on adavanced cell culture technologies - in the Chemiereport issues:
Chemiereport issue 2025/5 (in German).
Chemiereport issue 2023/3 (in German).
Who we are 
The ÖGMBT Working Group Cell Based Assays, Therapies and Products is an initiative of the former members of the ÖGTERM (Österreichische Gesellschaft für Tissue Engineering und Regenerative Medizin) Board, who decided to join the ÖGMBT in order to synergistically expand the field of scientific activities within ÖGMBT to topics in Regenerative Medicine.
Our aims
The Working Group Cell Based Assays, Therapies and Products aims at supporting the interaction of scientists, provides and disseminates information on current topics in the field in the field of basic and applied research on human cells and tissue engineering, cell-based assays, therapies and products. The Working Group supports the interdisciplinary exchange on current research approaches and methods in order to achieve an efficient use of existing competences and expertise and organizes events, such as seminars, symposia and round table discussions, addressing various target groups from various disciplines (e.g. from biological/technological disciplines, natural sciences, medical fields and social sciences as well as user groups/companies) and different background and levels (e.g. students, researchers, public relations officers/journalists).
What we offer
- Strengthening the network of research groups in basic and applied cell-based assays, therapies and products in Austria
- Promoting and supporting efforts for active exchange on methodological base
- Promotion of young researchers
- Creating an information and communication platform for scientists and public provision of information
Who should join
Persons from different disciplines, background and levels actively working and/or interested in current topics the rapidly evolving field of Cell Based Assays, Therapies and Products.
How to join
Registered ÖGMBT members can manage their ÖGMBT Working Groups memberships in the Intranet menue under MyData.
What you can expect
- Invitations to workshops, seminars and platform discussion
- Activation of exchange on practical level (e.g. lab protocols, technology offer)
Advisory Board
Prof. Dr. med. Martin Hildebrandt
Head of TUMCells, Interdisciplinary Center for Cell Therapy, Technical University Munich
Prof. Dr. Massimo Dominici
Associate Professor Medical Oncology at University of Modena and Reggio Emilia and Founder International Society of Cellular Therapies
Prof. Dr. Michael Ragunath
Head of Centre for Cell Biology and Tissue Engineering, ZHAW School of Life Sciences and Facility Management, Wädenswil
Prof. Dr. med. Reinhard Henschler
Head of Institute for Transfusion Medicine, University Clinics Leipzig
Upcoming Events
Upcoming Events
Stay tuned about an upcoming workshop in 2027! More information will be posted here in due time.
Previous Events
Previous Events
Year 2026:
18th ÖGMBT Annual Meeting
Session 6 - Emerging Technologies for Advanced Cell Culture Applications
The session was held as part of the 18th ÖGMBT Annual Meeting and was chaired by Dr. Isita Sagar and Prof. Cornelia Kasper from BOKU University.
The session focused on new approaches to improving cell culture systems and advancing their use in biomedical research, regenerative medicine and cell-based therapies. It featured four scientific talks and several poster presentations, creating plenty of opportunity for scientific exchange and discussion.
The keynote lecture was given by Nico Lachmann from Hannover Medical School, who spoke on “Engineering Human Immune Cell Production for Biomedical Applications and Cell Therapies.” He discussed the development and optimization of systems for producing human immune cells for biomedical research and therapeutic applications. In particular, he highlighted the need for reliable, scalable and well-controlled production processes that can generate immune cell products with the required identity, functionality, quality and safety.
The talk prompted an engaging discussion among the audience, with questions focusing on the challenges of translating experimental production strategies into robust platforms for biomedical applications and future cell therapies. It also highlighted the importance of bringing together cell biology, culture technologies and bioprocessing to support the development of clinically relevant immune cell products.
The session continued with presentations on advanced in vitro models, high-throughput cell encapsulation, automated NK cell production and stem cell platforms for women’s health research. Together, the talks and poster presentations reflected the broad range of emerging technologies currently shaping the field of advanced cell culture.
Year 2025:
3rd Workshop “Advanced Cell Culture Technologies” , July 3-4, 2025, BOKU, Vienna
The third “Advanced Cell Culture Technologies” workshop, organized by the ÖGMBT (Austrian Association of Molecular Life Sciences and Biotechnology) working group “Cell-Based Assays, Therapies and Products”, took place at BOKU during the first week of July.
Compared to its previous editions in 2018 and 2023, this year’s workshop saw a notable increase in both participant numbers and the diversity of presentations. For the first time, it was held as a 2-day event, spanning July 3rd to 4th. The overarching theme, “The Evolving Landscape of Cell Culture: Advancing Technologies and Future Prospects”, reflected the dynamic developments in the field and set the stage for a comprehensive and interdisciplinary program.
Three renowned experts provided stimulating keynote lectures, each followed by in-depth discussions:
- Prof. Dr. Michael Außerlechner (Medical University of Innsbruck) explored the topic of “Vascularized, 3D-bioprinted tissue-on-chip models for precision medicine drug testing”, highlighting the clinical potential of engineered microenvironments.
- Prof. Dr. Dominik Egger (Leibniz University Hannover) presented on “Hypoxia in physiologic 3D stem cell culture systems”, emphasizing the importance of mimicking in vivo-like conditions in stem cell research.
- Dr. Heidrun Holland (University of Leipzig) addressed “Genetic integrity in basic and applied cell-based products and therapies”, underlining a crucial aspect for ensuring safety and efficacy in cell-based innovations.
In the “Company Sessions”, eight exhibiting companies showcased their latest innovations in cell culture technologies. Participants had the opportunity to learn about new laboratory tools and approaches, engage directly with company representatives, and explore these offerings in more detail at the exhibition booths.
Eighteen researchers took part in the poster flash talks, providing concise summaries of their scientific findings. These were followed by a poster walk, during which attendees could discuss the work in more detail with the presenters. This year´s poster prize was awarded to Marina Rodríguez Harzi for her outstanding contribution titled “Characterization of hydrogel-based and scaffold-free 3D in vitro constructs using genetically encoded biosensors for hypoxia and reactive oxygen species detection”. Congratulations on this achievement!
Despite a packed program and exceptionally hot weather, many participants joined the optional networking dinner on the evening of the first day. The informal setting encouraged further professional exchange and helped strengthen ties within the scientific community.
The second day featured additional presentations and discussions, rounding off a highly successful event. The organizing committee was pleased with the positive feedback from both participants and exhibitors. “It is inspiring to see how great the interest in innovative cell culture technologies is and how engaged the community is in the discussion”, said Prof. Cornelia Kasper, expressing gratitude on behalf of the organizing team and thanking participants, ÖGMBT office Team and exhibitors for making the workshop a great success.
For anyone interested in contributing to or benefiting from the exchange within this vibrant field, membership and active participation in the ÖGMBT working group “Cell-Based Assays, Therapies and Products” is warmly encouraged. You can join anytime via the following link:
👉 https://oegmbt.at/ueber-uns/working-groups/cbatp


Organizing Team and key note speaker (from left to right): Dr.in Heidrun Holland, Prof. Dominik Egger, Ass.Prof.in Jule Michler, Prof.in Janina Burk, Prof.in Cornelia Kasper, Prof.in Doris Wilfingseder, Prof. Michael Außerlechner, Dr.in Isita Sagar

Poster Prizes were awarded to Marina Rodríguez Harzi (left, Leibniz University Hannover) by Ass.Prof. Jule Michler (right, VetMedUni Vienna)
Year 2023:
This was the Workshop „Advanced Cell Culture Technologies”, Fri., March 17, 2023, BOKU, Vienna
The Working Group Cell Based Assays, Therapies and Products organized the first workshop "Advanced Cell Culture Technologies" on March 17, 2023

It was a great pleasure to organize and host the ÖGMBT workshop “Advanced Cell Culture Technologies” of the ÖGMBT working group “Cell based assays, therapies and products” at BOKU. It was an intense day full of exciting talks, lively discussions and networking activities.
We would like to thank all participants and the organizers of the ÖGMBT and BOKU for making this event a great success; special thanks go to our keynote speakers PD Dr. Antonina Lavrentieva and Prof. Dr. Jan Hansmann, who shared unique insights into how cells perceive their 3D environment and how automation can enhance our research output. Congratulations to our poster prize winners Sonya Ciulean (Fraunhofer IZI, Leipzig, Germany) and Julia Moldaschl (BOKU), who won free admission for the next ÖGMBT Annual Meeting in Salzburg.
This workshop was supported by PL BioScience GmbH and organized by Cornelia Kasper, Dominik Egger & Farhad Chariyev-Prinz.




In addition to insightful and exciting keynote lectures by by PD Dr. Lavrentieva (Leibniz Universität Hannover) and Prof. Dr. Hansmann (Fraunhofer ISC, Würzburg), who shared their views on advanced 3D cell culture technologies and potential application of automation and artificial intelligence in research, the workshop was complemented by a variety of short talks that covered a wide range of relevant topics, including 3D tumor models, 3D encapsulation strategies and employment of mechanical cues in tissue engineering applications.
In the second half of the event the programm was rounded up by a lively poster session, which allowed for further scientific exchange. We warmly congratulate the two winners of the poster award Sonya Ciulean (Fraunhofer IZI, Leipzig) and Julia Moldaschl (BOKU).


